RCKT: Rocket Pharmaceuticals Inc
今日RCKT汇率已更改-4.96%。当日,交易品种以低点4.16和高点4.68进行交易。
关注Rocket Pharmaceuticals Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
RCKT新闻
- Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
- Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program
- Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Alpha Technology Group (NASDAQ:ATGL), Fulcrum Therapeutics (NASDAQ:FULC)
- RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy
- Wells Fargo, Walmart Lead Tuesday’s Market Cap Stock Movers
- Goldman Sachs, Avago tech lead market cap stock movers on Tuesday
- FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock - Rocket Pharmaceuticals (NASDAQ:RCKT)
- FDA accepts Rocket Pharmaceuticals’ gene therapy BLA for rare disease
- Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On Tuesday - American Resources (NASDAQ:AREC), Albertsons Companies (NYSE:ACI)
- Leerink Partners下调Rocket Pharmaceuticals股票目标价,因其撤回生物制品许可申请
- Leerink Partners lowers Rocket Pharmaceuticals stock price target on BLA withdrawal
- 火箭制药公司宣布Pedro Granadillo将辞去董事会职务
- Rocket Pharmaceuticals announces board resignation of Pedro Granadillo
- 火箭制药公司在美国撤回基因疗法RP-L102的BLA申请
- Rocket Pharmaceuticals withdraws BLA for gene therapy RP-L102 in the US
- 火箭制药公司宣布董事会变更及任命新董事
- Rocket Pharmaceuticals announces board changes and new director appointment
- Cantor Fitzgerald重申火箭制药公司股票评级为"超配"
- Rocket Pharmaceuticals stock rating reiterated at Overweight by Cantor Fitzgerald
- 火箭制药公司与Kinnari Patel博士签订离职和咨询协议
- Rocket Pharmaceuticals enters separation and consulting agreements with Dr. Kinnari Patel
- Rare Disease Therapy Approvals By FDA Speed Up Via New Process - Neurogene (NASDAQ:NGNE)
常见问题解答
RCKT股票今天的价格是多少?
Rocket Pharmaceuticals Inc股票今天的定价为4.41。它在4.16 - 4.68范围内交易,昨天的收盘价为4.64,交易量达到6143。RCKT的实时价格图表显示了这些更新。
Rocket Pharmaceuticals Inc股票是否支付股息?
Rocket Pharmaceuticals Inc目前的价值为4.41。股息政策取决于公司,而投资者也会关注-32.98%和USD。实时查看图表以跟踪RCKT走势。
如何购买RCKT股票?
您可以以4.41的当前价格购买Rocket Pharmaceuticals Inc股票。订单通常设置在4.41或4.71附近,而6143和-3.71%显示市场活动。立即关注RCKT的实时图表更新。
如何投资RCKT股票?
投资Rocket Pharmaceuticals Inc需要考虑年度范围2.19 - 8.27和当前价格4.41。许多人在以4.41或4.71下订单之前,会比较-10.55%和。实时查看RCKT价格图表,了解每日变化。
Rocket Pharmaceuticals Inc股票的最高价格是多少?
在过去一年中,Rocket Pharmaceuticals Inc的最高价格是8.27。在2.19 - 8.27内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Rocket Pharmaceuticals Inc的绩效。
Rocket Pharmaceuticals Inc股票的最低价格是多少?
Rocket Pharmaceuticals Inc(RCKT)的最低价格为2.19。将其与当前的4.41和2.19 - 8.27进行比较,可以发现潜在的长期切入点。观看RCKT在图表上的实时走势以获取更多详细信息。
RCKT股票是什么时候拆分的?
Rocket Pharmaceuticals Inc历史上曾经历过股票拆分。这些变化在公司行动后的、4.64和-32.98%中可见。
- 前一天收盘价
- 4.64
- 开盘价
- 4.58
- 卖价
- 4.41
- 买价
- 4.71
- 最低价
- 4.16
- 最高价
- 4.68
- 交易量
- 6.143 K
- 日变化
- -4.96%
- 月变化
- -10.55%
- 6个月变化
- 35.69%
- 年变化
- -32.98%